DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology

Related Experiment Video

Updated: May 11, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Kahlin Cheung-Ong1, Guri Giaever, Corey Nislow

  • 1Department of Molecular Genetics and the Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.

Chemistry & Biology
|May 28, 2013
PubMed

Insights

This review explores DNA-damaging agents in cancer therapy, highlighting their limitations and the potential of chemical genomics to evaluate new compounds and understand DNA damage response networks.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • DNA-damaging agents are foundational in cancer chemotherapy but face challenges.
  • Understanding their cellular mechanisms is crucial for optimizing efficacy and managing toxicity.
  • Drug resistance and dose-limiting toxicities hinder the effectiveness of current treatments.

Purpose of the Study:

  • To review current clinical DNA-damaging agents and their limitations.
  • To discuss the application of chemical genomics in cancer research.
  • To explore how chemical genomics can evaluate novel anticancer compounds and elucidate the DNA damage response network.

Main Methods:

  • Literature review of existing DNA-damaging chemotherapy agents.
  • Analysis of mechanisms underlying drug resistance and toxicity.
  • Exploration of chemical genomics approaches for drug discovery and mechanism elucidation.

Main Results:

  • Current DNA-damaging agents have significant limitations including resistance and toxicity.
  • Chemical genomics offers a powerful platform for dissecting complex biological networks.
  • This approach can reveal novel insights into the DNA damage response network.

Conclusions:

  • Further research into DNA-damaging agents is needed to overcome clinical limitations.
  • Chemical genomics presents a promising strategy for evaluating novel anticancer compounds.
  • Understanding the DNA damage response network is key to developing more effective cancer therapies.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Base-pairing and DNA Repair02:27

Base-pairing and DNA Repair

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,